IQVIA Holdings Inc.

IQV Healthcare Diagnostics & Research

IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024.

Revenue
+8.00%
EPS
+10.2%
Free cash flow
−21.3%
Total debt
+7.42%

Quarter to September 2026, against a year earlier

269.78 4.90 +1.85%
Market cap
$43.7B
P/E
31.8×
Fwd P/E
34.8×
Dividend yield
—
F-score
4/9
Altman Z
2.05
Beneish M
−2.59
Dividend safety
n/a
Older periods Dec '25 Mar '26 Jun '26 Sep '26
P/E ratio

+8 more quarters

28.43 20.95 23.77 32.29
P/S ratio
2.38 1.73 1.89 2.56
P/FCF ratio
18.23 13.11 14.21 21.30
P/Operating CF
52.72 46.47 57.52 53.67
P/B ratio
5.84 4.52 5.09 6.52
EV/Sales
3.21 2.55 2.71 3.35
EV/EBITDA
15.63 12.52 13.51 16.74
EV/FCF
24.61 19.37 20.37 27.86
Current Ratio
0.75 0.75 0.71 0.83
Net Debt/EBITDA
14.30 16.99 17.31 15.19
Debt/Equity
2.37 2.49 2.54 2.37
Earnings Yield
3.52% 4.77% 4.21% 3.10%
Free Cash Flow Yield
5.49% 7.63% 7.04% 4.70%
Free Cash Flow per Share
3.26 2.92 2.17 4.05
Book value per Share
38.57 37.70 37.94 41.23
Free Cash Flow
561.00 491.00 360.00 667.00
EV/EBIT
23.98 19.30 20.91 26.10
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026